CN114555060A - 具有水溶性黏膜黏附性聚合物的离子交换组合物 - Google Patents
具有水溶性黏膜黏附性聚合物的离子交换组合物 Download PDFInfo
- Publication number
- CN114555060A CN114555060A CN202080071199.0A CN202080071199A CN114555060A CN 114555060 A CN114555060 A CN 114555060A CN 202080071199 A CN202080071199 A CN 202080071199A CN 114555060 A CN114555060 A CN 114555060A
- Authority
- CN
- China
- Prior art keywords
- water
- tablet
- oral tablet
- soluble anionic
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/599,991 US20210106516A1 (en) | 2019-10-11 | 2019-10-11 | Ion-Exchange Composition With Water-Soluble Mucoadhesive Polymers |
| US16/599,991 | 2019-10-11 | ||
| PCT/DK2020/050280 WO2021069044A1 (en) | 2019-10-11 | 2020-10-09 | An ion-exchange composition with water-soluble mucoadhesive polymers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114555060A true CN114555060A (zh) | 2022-05-27 |
Family
ID=73198078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080071199.0A Pending CN114555060A (zh) | 2019-10-11 | 2020-10-09 | 具有水溶性黏膜黏附性聚合物的离子交换组合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210106516A1 (https=) |
| EP (1) | EP4041191A1 (https=) |
| JP (1) | JP7763166B2 (https=) |
| CN (1) | CN114555060A (https=) |
| CA (1) | CA3153792A1 (https=) |
| WO (1) | WO2021069044A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022234522A1 (en) * | 2021-05-06 | 2022-11-10 | Nicoventures Trading Limited | Oral compositions and related methods for reducing throat irritation |
| CA3233375A1 (en) | 2021-09-30 | 2023-04-06 | Michael Zawadzki | Oral product with a basic amine and an ion pairing agent |
| US12295412B2 (en) | 2022-01-28 | 2025-05-13 | Altria Client Services Llc | Oral pouch product |
| JP2026509969A (ja) * | 2023-01-27 | 2026-03-26 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | 活性成分の経口送達のためのシステム |
| WO2024156323A1 (en) * | 2023-01-27 | 2024-08-02 | Fertin Pharma A/S | An adhesive oral disc for sustained release of cannabinoids |
| DK182278B1 (en) * | 2023-07-07 | 2026-02-04 | Fertin Pharma As | Dissolvable orally adhering tablet |
| DK182273B1 (en) * | 2023-07-07 | 2026-01-30 | Fertin Pharma As | Dissolvable orally adhering nicotine tablet |
| WO2025011727A1 (en) * | 2023-07-07 | 2025-01-16 | Fertin Pharma A/S | Dissolvable orally adhering nicotine tablet |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997042941A2 (en) * | 1996-05-13 | 1997-11-20 | Novartis Consumer Health S.A. | Buccal delivery system |
| WO2000025757A1 (en) * | 1998-10-29 | 2000-05-11 | Merck & Co., Inc. | Sustained release delivery of highly water-soluble compounds |
| US20050181050A1 (en) * | 2004-01-28 | 2005-08-18 | Collegium Pharmaceutical, Inc. | Dosage forms using drug-loaded ion exchange resins |
| EP2233134A1 (en) * | 2009-03-27 | 2010-09-29 | McNeil AB | Multi-portion intra-oral dosage form with organoleptic properties |
| WO2012083947A1 (en) * | 2010-12-21 | 2012-06-28 | Fertin Pharma A/S | Chewing gum composition comprising cross-linked polyacrylic acid |
| CN104271137A (zh) * | 2012-03-26 | 2015-01-07 | 阿特法克特里公司 | 包含封装在水不溶性袋中的粉末的尼古丁口服递送产品,其中所述粉末包括尼古丁和口香糖组合物 |
| US20170172995A1 (en) * | 2015-09-08 | 2017-06-22 | Venkateswara Rao Repaka | Pharmaceutical compositions of Nicotine and process for preparation thereof |
| WO2018113916A1 (en) * | 2016-12-20 | 2018-06-28 | Fertin Pharma A/S | A mucoadhesive oromucosal formulation comprising a nicotine complex |
| CN109952092A (zh) * | 2016-11-18 | 2019-06-28 | 费尔廷制药公司 | 包含独立的黏合剂和赤藓糖醇的片剂 |
| CN109963553A (zh) * | 2016-11-18 | 2019-07-02 | 费尔廷制药公司 | 经口递送载剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3901248A (en) | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
| WO2005053691A2 (en) * | 2003-12-02 | 2005-06-16 | Fertin Pharma A/S | Nicotine delivery product and method for producing it |
| WO2005055945A2 (en) * | 2003-12-08 | 2005-06-23 | Gel-Del Technologies, Inc. | Mucoadhesive drug delivery devices and methods of making and using thereof |
| CA2758618C (en) * | 2009-04-24 | 2017-03-28 | Omya Development Ag | Particulate material for controlled release of active ingredients |
| US10632076B2 (en) * | 2016-11-18 | 2020-04-28 | Fertin Pharma A/S | Tablet comprising separate binder and erythritol |
| US11058633B2 (en) * | 2018-05-17 | 2021-07-13 | Fertin Pharma A/S | Disintegrating oral tablet suitable for active pharmaceutical ingredients |
-
2019
- 2019-10-11 US US16/599,991 patent/US20210106516A1/en active Pending
-
2020
- 2020-10-09 CN CN202080071199.0A patent/CN114555060A/zh active Pending
- 2020-10-09 EP EP20803744.0A patent/EP4041191A1/en active Pending
- 2020-10-09 CA CA3153792A patent/CA3153792A1/en active Pending
- 2020-10-09 WO PCT/DK2020/050280 patent/WO2021069044A1/en not_active Ceased
- 2020-10-09 JP JP2022521453A patent/JP7763166B2/ja active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997042941A2 (en) * | 1996-05-13 | 1997-11-20 | Novartis Consumer Health S.A. | Buccal delivery system |
| WO2000025757A1 (en) * | 1998-10-29 | 2000-05-11 | Merck & Co., Inc. | Sustained release delivery of highly water-soluble compounds |
| US20050181050A1 (en) * | 2004-01-28 | 2005-08-18 | Collegium Pharmaceutical, Inc. | Dosage forms using drug-loaded ion exchange resins |
| EP2233134A1 (en) * | 2009-03-27 | 2010-09-29 | McNeil AB | Multi-portion intra-oral dosage form with organoleptic properties |
| WO2012083947A1 (en) * | 2010-12-21 | 2012-06-28 | Fertin Pharma A/S | Chewing gum composition comprising cross-linked polyacrylic acid |
| CN104271137A (zh) * | 2012-03-26 | 2015-01-07 | 阿特法克特里公司 | 包含封装在水不溶性袋中的粉末的尼古丁口服递送产品,其中所述粉末包括尼古丁和口香糖组合物 |
| US20170172995A1 (en) * | 2015-09-08 | 2017-06-22 | Venkateswara Rao Repaka | Pharmaceutical compositions of Nicotine and process for preparation thereof |
| CN109952092A (zh) * | 2016-11-18 | 2019-06-28 | 费尔廷制药公司 | 包含独立的黏合剂和赤藓糖醇的片剂 |
| CN109963553A (zh) * | 2016-11-18 | 2019-07-02 | 费尔廷制药公司 | 经口递送载剂 |
| WO2018113916A1 (en) * | 2016-12-20 | 2018-06-28 | Fertin Pharma A/S | A mucoadhesive oromucosal formulation comprising a nicotine complex |
Non-Patent Citations (2)
| Title |
|---|
| CALUM R PARK ET AL: "Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy", 《INTERNATIONAL JOURNAL OF PHARMACEUTICS》, vol. 237, 31 December 2002 (2002-12-31), pages 215 - 226, XP002279251, DOI: 10.1016/S0378-5173(02)00041-8 * |
| 国家食品药品监督管理局药品审评中心编: "《药品技术评价文集》", 中国医药科技出版社, pages: 226 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3153792A1 (en) | 2021-04-15 |
| EP4041191A1 (en) | 2022-08-17 |
| US20210106516A1 (en) | 2021-04-15 |
| JP2022552491A (ja) | 2022-12-16 |
| WO2021069044A1 (en) | 2021-04-15 |
| JP7763166B2 (ja) | 2025-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7763166B2 (ja) | 水溶性粘膜付着性ポリマーを有するイオン交換組成物 | |
| CN111432840B (zh) | 固体经口烟碱制剂 | |
| EP3720418B1 (en) | Nicotine tablet | |
| US12478579B2 (en) | Compressed nicotine lozenge | |
| CA3085066C (en) | Formulations providing high nicotine concentrations | |
| CN110621307A (zh) | 含有烟碱的口香糖组合物 | |
| JPH0948726A (ja) | 口腔内速崩壊性製剤およびその製法 | |
| AU2003255822A1 (en) | Fast dissolving and taste masked oral dosage form comprising sildenafil | |
| EP4447714B1 (en) | Nicotine tablet | |
| CN101965180B (zh) | 含有异麦芽酮糖醇的混合物 | |
| WO2004089343A1 (en) | Water soluble tablets | |
| RU2812603C1 (ru) | Ионообменная композиция с водорастворимыми мукоадгезивными полимерами | |
| Nagpal et al. | Patent innovations in fast dissolving/disintegrating dosage forms | |
| US20240091367A1 (en) | Orally disintegrating palatable formulations of drotaverine and method of preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |